Michael Grey - Director, Horizon Therapeutics Public Ltd Co
As of May 2, 2022
Michael Grey Net Worth
- Net worth is estimated to be at least $31.5M
- Owns at least 62,290 units of Horizon Therapeutics Public Ltd Co stock
- Sold an estimated value of $3.31M in the last 11 years at Horizon Therapeutics Public Ltd Co
Michael Grey Trading
- Largest purchase of shares was 10,000 units , worth over $94.8K on May 10, 2017
- Largest sale of shares was 15,000 units , worth over $1.35M on April 13, 2021
- In total has made about 22 transactions over 11 years
- Usually trades in May, with the busiest year in 2020
MICHAEL GREY
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Michael Grey Mailing Address
- Mailing address is C/o Sgx Pharmaceuticals, Inc. 10505 Roselle Street San Diego CA 92121 CA
Horizon Therapeutics Public Ltd Co Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Timothy P. Walbert | 2020 | $1,146,542 | - | $199,548 | $199,548 | $199,548 | $199,548 | $21,632,803 |
| Timothy P. Walbert | 2019 | $1,108,700 | - | $226,871 | $226,871 | $226,871 | $226,871 | $13,873,172 |
| Timothy P. Walbert | 2018 | $1,076,250 | - | $160,363 | $160,363 | $160,363 | $160,363 | $16,796,894 |
| Paul W. Hoelscher | 2020 | $600,569 | - | $106,485 | $106,485 | $106,485 | $106,485 | $5,915,146 |
| Paul W. Hoelscher | 2019 | $580,748 | - | $120,135 | $120,135 | $120,135 | $120,135 | $4,443,588 |
| Paul W. Hoelscher | 2018 | $563,750 | - | $104,332 | $104,332 | $104,332 | $104,332 | $7,034,386 |
| Andy Pasternak | 2020 | $669,021 | $250,000 | $66,872 | $66,872 | $66,872 | $66,872 | $5,826,126 |
| Andy Pasternak | 2019 | $108,333 | $500,000 | $19,188 | $19,188 | $19,188 | $19,188 | $2,924,542 |
| Jeffrey W. Sherman, M.D., FACP | 2020 | $578,731 | - | $92,545 | $92,545 | $92,545 | $92,545 | $5,261,300 |
| Jeffrey W. Sherman, M.D., FACP | 2019 | $559,630 | - | $95,222 | $95,222 | $95,222 | $95,222 | $3,568,496 |
| Jeffrey W. Sherman, M.D., FACP | 2018 | $543,250 | - | $68,263 | $68,263 | $68,263 | $68,263 | $3,678,874 |
| Barry J. Moze | 2020 | $628,960 | - | $75,659 | $75,659 | $75,659 | $75,659 | $5,073,877 |
| Barry J. Moze | 2019 | $608,201 | - | $58,744 | $58,744 | $58,744 | $58,744 | $4,662,510 |
| Barry J. Moze | 2018 | $590,400 | - | $35,114 | $35,114 | $35,114 | $35,114 | $2,732,565 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm
Horizon Therapeutics Public Ltd Co Insider Trading
- The most recent transaction was 25,000 units sold on May 20, 2022 by Timothy Walbert worth over $2.25M
- In the last 11 years, insiders at Horizon Therapeutics Public Ltd Co sold an estimated value of $677.16M and bought an estimated value of $118.92M
- The most active traders are Timothy Walbert, Chairman, Jeffrey Sherman, EVP and Chief Medical Officer, and Paul Hoelscher, EVP
- Insider trading is most common in May and January, with the busiest year in 2021
Horizon Therapeutics Public Ltd Co Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||